Spectrum Pharmaceutecals Inc (SPPI)

[antihama]

Looks like I'll be eating my hat. Salt and pepper please.

That sounds funny but I'm not a happy camper right now. How could JT et al. screw that up? I actually just got in from some travelling and fired up the computer to see the PR that pozi did not receive BTD. Will listen to the CC when available later. With the pozi data from MDA and JTs confidence at various CCs I felt pretty strong about getting BTD. I do get some solace from the pr stating

“Data required for the NDA filing for previously treated NSCLC patients with EGFR exon 20 insertion mutations is expected to come from an 87-patient cohort in our ZENITH20 study. We expect to complete enrollment in this cohort in the first quarter of 2019, and announce topline data in the second half of 2019.”

which if if you view "the second half of 2019" timeline through the Rolontis lens that means the end of Dec 2019 (slightly kidding here)

The kicker is I'm not feeling lovely dovey about Rolontis and Spectrum taking this long to submit the BLA. Hopefully they don't screw that up.